Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.
about
Selection of patients with hepatocellular carcinoma for liver transplantation: Past and futureRole of liver transplantation for hepatocellular carcinomaOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationHow grim is hepatocellular carcinoma?Hepatocellular carcinoma: a reviewLiver transplantation for advanced hepatocellular carcinomaHepatocellular carcinoma: A comprehensive review2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaPretreatment assessment of hepatocellular carcinoma: expert consensus statement.Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantationAn evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithmUpdates in the management of hepatocellular carcinomaFrom minimal to maximal surgery in the treatment of hepatocarcinoma: A reviewScoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation.Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Surgical treatment for hepatocellular carcinomaTransarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.Liver cancer: Approaching a personalized care.Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Current status of multimodal & combination therapy for hepatocellular carcinoma.Factors predicting survival after post-transplant hepatocellular carcinoma recurrenceIncidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver TransplantationUp-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysisMagnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma."Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA.Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.Treatment options in hepatocellular carcinoma today.Which matters most: number of tumors, size of the largest tumor, or total tumor volume?Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma.Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?Living donor liver transplantation for patients with hepatocellular carcinomaReview article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria.
P2860
Q26771246-145DF5B5-A48D-43E3-B3EA-64007FA268D2Q26822581-2304C148-EADA-4F01-9DC2-E332A8599AF8Q26864478-12B2D7C3-2F0E-4BCC-B87E-CD919E9B2725Q27001669-C7426370-E106-45BF-B67F-57D0458BA88DQ28069290-419D802A-FFBA-4D3C-BFBE-19575702C2FCQ28074653-67D98CE4-63EC-433C-BEC5-6C58DD39B8D7Q28087638-F02D01FB-AF87-4BC2-9D53-84A842E6DF8CQ28392783-EB720287-9CF4-4B5E-89AB-025D3E287382Q28394414-5721DCAA-69F9-48BF-8B3E-F3A03BD18BC8Q30432108-9505D241-23F5-4FB6-88F1-0C35D44F1816Q30962577-CF3F815B-7273-4F55-BC24-25DC86FFFF83Q33718321-3B5AAC60-8DF1-4FAB-B056-C7FB4D600119Q34417009-469BACD5-3C17-45A3-985B-30E0D7A67CF4Q34571160-D66EFEEE-6119-4D12-8953-CFC6AD9B396FQ34966860-05F0C2EF-7724-4DFE-8B73-ED5EF6570978Q34977062-6AA86A3E-A133-42B8-841A-BC92A3FE17DCQ35051942-3D91DF55-9854-47E4-A4B8-459A7FC303B5Q35163735-DF166B28-2EEA-4F25-8AF9-8E904D396FECQ35166162-3B5B2063-E2B2-44FB-BC26-4F3336DC5D15Q35268118-70744445-A824-4422-9E05-DCC25501F6A4Q35785027-C95A85B0-4365-4EDA-90FB-CA4E79310B5DQ35903794-00339EB0-941E-46A1-93F9-68A8836B5F76Q36082480-60CD6F51-DA04-438D-9070-A4D1580EB1A4Q36436294-C3E3F341-FBB6-4459-A57F-33946DA08A40Q36662813-CC82F716-DDBD-438A-84B8-B8CF30B65D5CQ37049395-61315CE2-A1A7-4F38-B61D-261839730A6AQ37203571-8694F9CF-A769-41F9-B266-064BFDC00541Q37247967-EB54083C-6EA5-4AE3-9BE5-72804336B56EQ37358673-360C1B6B-97A2-47A4-94AF-7EDB6E0FC59AQ37579484-8C074C59-9FB3-47B7-8150-8A8027CB74BDQ37636484-0036D7A0-4D55-4BF3-BDFB-C4D954AB3DC0Q37863929-D681F5EC-56CA-4FD4-BD60-EC35F8A43A12Q37876384-8F93E39B-E093-461E-8243-131A457C823EQ37900264-C7272ED1-C50C-4E51-BACA-DEE987E3E5C0Q37947043-3128A740-83A9-4E62-9825-DD50F1C577C4Q37952030-5CB6C34D-0D69-45A2-B0A9-3A5A0316A535Q37995306-A685886D-3B60-4908-9E70-2B114513FC7FQ38065315-4411C8EE-7926-45F9-91B3-4FB2F3198793Q38221511-B6F5CED5-FA87-43E3-9B25-71932F43522AQ38243059-913869C7-587C-4A94-8EA1-81985D4DA8B0
P2860
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@en
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@nl
type
label
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@en
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@nl
prefLabel
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@en
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@nl
P2093
P356
P1476
Total tumor volume predicts ri ...... with hepatocellular carcinoma.
@en
P2093
A M James Shapiro
Christian Toso
David L Bigam
David R Grant
James Trotter
Joshua Lancaster
Norman M Kneteman
Paul D Greig
Shimul Shah
P304
P356
10.1002/LT.21484
P577
2008-08-01T00:00:00Z